4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

Off-label use of medication may be presented in these guidelines if a sufficient level of
evidence shows that it can be considered medically appropriate to a given condition and if …

The aim of this ESC Guideline is to help health professionals manage people with heart
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …

Risk stratification scheme. Risk stratification aiming at assessing the risk of VAs and SCD in
patients with MVP, involving two phases based on the clinical and imaging context and the …

Background: Optimal timing for catheter ablation of ventricular tachycardia is an important
unresolved issue. There are no randomized trials evaluating the benefit of ablation after the …

This international multidisciplinary document intends to provide clinicians with evidence‐
based practical patient‐centered recommendations for evaluating patients and decedents …

Premature ventricular complexes (PVCs) are extremely common, found in the majority of
individuals undergoing long-term ambulatory monitoring. Increasing age, a taller height, a …

Background: Catheter ablation as first-line therapy for ventricular tachycardia (VT) at the time
of implantable cardioverter defibrillator (ICD) implantation has not been adopted into clinical …

SciELO - Brasil - Diretriz da SBC sobre Diagnóstico e Tratamento de Pacientes com
Cardiomiopatia da Doença de Chagas – 2023 Diretriz da SBC sobre Diagnóstico e …

Aims This study evaluated the prognosis and prognostic factors of patients with cardiac
sarcoidosis (CS), an underdiagnosed disease. Methods and results Patients from a …